CW-2 Cells

The CW-2 cell line is derived from human colorectal carcinoma. Established from the tumor tissue of a female patient, this cell line exhibits epithelial morphology and has been used primarily to study colorectal cancer mechanisms, including tumor growth, metastasis, and the tumor microenvironment. The CW-2 cells are known for their robust ability to form colonies in soft agar, indicating a high degree of tumorigenicity, which makes them a valuable model for in vitro experiments focusing on cancer aggressiveness and drug responses. Genetically, CW-2 cells carry mutations typical of colorectal cancers, such as alterations in the APC, KRAS, and TP53 genes. These mutations not only contribute to their malignant phenotype but also make them relevant for studies on genetic pathways involved in colorectal cancer progression and response to therapy. CW-2 has been instrumental in pharmacological research, providing insights into the efficacy and mechanism of action of various chemotherapeutic agents. Moreover, their response to environmental and genetic modifications can help in the development of targeted therapies for colorectal cancer. Due to the genetic profile and the aggressive nature of the CW-2 cell line, it is also utilized in research focusing on cancer stem cells and resistance to chemotherapy, offering a comprehensive model for understanding the dynamics of cancer treatment resistance and relapse. Research using CW-2 cells helps in deciphering the complex interactions within the tumor microenvironment that support cancer survival and proliferation, making them indispensable in advanced cancer research.